Clinical Trial Update: Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating KP104 for Glomerulonephritis to assess efficacy, safety, pharmacokinetics, and pharmacodynamics; the study status is NOT_YET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis

Drugs mentioned

• KP104 (KP104)

Snippet

Sponsor: Kira Pharmacenticals (US), LLC. | Conditions: Glomerulonephritis | Phase 2 | Status: NOT_YET_RECRUITING